1.2 million cholera rapid diagnostic test shipped 14 country largest-ever global deployment first shipment landing today Malawi.This first official deployment test Gavi Vaccine Alliance improve timely detection monitoring outbreak effectiveness vaccination campaign response current outbreak targeting future preventive vaccination efforts.The global cholera rapid diagnostic test procurement programme collaboration Gavi UNICEF FIND partner arrival rapid diagnostic test RDT kit cholera Malawi today signal start global programme see 1.2 million test distributed 14 country high risk cholera next several month Countries receive kit coming week largest-ever global deployment include currently severely impacted cholera outbreak Ethiopia Somalia Syria Zambia programme improve timeliness accuracy outbreak detection response boosting routine surveillance testing capacity helping rapidly identify probable cholera case Critically also help country monitor trend build evidence base future preventive programme supporting achievement national cholera control elimination target global cholera diagnostics programme funded coordinated Gavi Vaccine Alliance Gavi procurement delivery country led UNICEF undertaken collaboration Global Task Force Cholera Control GTFCC developed partnership FIND led development target product profile describing required characteristic cholera RDTs organization initial shipment signal start programme aim see partner deploy RDTs additional country expressed interest future Long-term sustainability programme depends successful fundraising Gavi ’ next strategic period 2026 2030 effort rapid diagnostic test two manufacturer – to-date supplied via UNICEF use outbreak response – used routinely cholera surveillance Pilot study across Democratic Republic Congo DRC Niger Nepal funded Gavi led United States Centers Disease Control Prevention CDC Johns Hopkins University JHU Epicentre/ Médecins Sans Frontières helped increase understanding effective rapid testing strategy Preliminary insight study still ongoing helped inform programme design – making rollout test scale effective Cholera surging globally since 2021 high case fatality rate despite availability simple effective affordable treatment large number outbreak led unprecedented demand vaccine impacted country global oral cholera vaccine supply increased eighteen-fold 2013 2023 large sustained spike demand compared current availability put strain global stockpile Preventive vaccination campaign delayed preserve dos emergency outbreak response effort Recurring outbreak country emergency vaccination campaign already implemented highlight need improved speed accuracy identifying area new persistent transmission – enabling area targeted initial outbreak response effort 2021 Gavi Board approved US 55 million funding support diagnostics programme 2022 and- 2025 across cholera yellow fever measles rubella meningococcal meningitis typhoid – aim improve disease surveillance outbreak detection response design preventive programme Gavi opened cholera diagnostics application window June 2023 – still open – far 14 country submitted application approved Independent Review Committee expert 2023 Gavi also launched preventive cholera vaccination programme support country long-term cholera control – strategy successfully led decrease outbreak disease yellow fever meningitis Cholera acute intestinal infection spread food water contaminated faeces containing bacterium Vibrio cholerae rise cholera driven continued gap access safe water sanitation failure quickly detect outbreak limit spread community impacted often access basic health service situation made worse climate-related factor conflict population displacement face ongoing surge partner working cholera control urgently called country manufacturer partner invest timely outbreak response case management rapid access treatment increased production affordable vaccine urgent improvement access basic water sanitation service impacted communities.To effective multisectoral strategy control cholera must guided timely reliable cholera surveillance data Surveillance support early detection quick response outbreak also play central role providing stakeholder cholera prevention control pillar data need target design implement evaluate intervention 2023 GTFCC updated recommendation favor strategic routine systematic testing suspected cholera case expanded use RDTs strengthen cholera surveillance global cholera RDT procurement program provides additional support required eligible country implement recommendation “ experiencing unprecedented multi-year upsurge cholera case worldwide today ’ announcement provides critical boost fight disease rise infection driven continued gap access safe water sanitation inability reach vulnerable community put risk climate change conflict displacement ” said Aurélia Nguyen Chief Programme Officer Gavi Vaccine Alliance “ Routine use diagnostics bolster cholera surveillance impacted country must leveraged better target vaccination effort play critical role multisectoral cholera prevention control programmes. ” “ Despite cholera preventable easily treatable child continue suffer potentially fatal disease working partner front novel way stem outbreak ” said Leila Pakkala Director UNICEF Supply Division “ Surveillance diagnostics help pinpoint hotspot great precision allows partner target cholera vaccine exactly time place limited supply save lives. ” “ ’ tragedy cholera—a preventable treatable disease—continues afflict kill today need urgent action front including commitment country clean water sanitation hygiene ” said Dr Michael Ryan Executive Director ’ Health Emergencies Programme “ welcome deployment rapid cholera test equip health worker critical timely data needed stop outbreak early direct effort better prevent treat cholera. ” “ Cholera spreading area free disease many year demanding swift multifaceted strategy direct limited resource critical area save life Accurate high-quality testing surveillance measure vital spot disease emerging confirm cholera case amidst diarrheal illness evaluate success preventative measure vaccine ” said Dr Sergio Carmona Acting CEO Chief Medical Officer FIND.Note editorsGaviThe 14 country received Gavi IRC approval far Cameroon Democratic Republic Congo Ethiopia Malawi Mozambique Nepal Nigeria Pakistan Sierra Leone Somalia Syria Uganda Zambia Zimbabwe.Cholera-related content including photo video b-rollStories community choleraUNICEFCholera-related b-roll photo FIND Cholera RDT target product profile GaviGavi Vaccine Alliance public-private partnership help vaccinate half world ’ child world ’ deadliest disease Vaccine Alliance brings together developing country donor government World Health Organization UNICEF World Bank vaccine industry technical agency civil society Bill Melinda Gates Foundation private sector partner View full list donor government leading organisation fund Gavi ’ work here.Since inception 2000 Gavi helped immunise whole generation – 1 billion child – prevented 17.3 million future death helping halve child mortality 78 lower-income country Gavi also play key role improving global health security supporting health system well funding global stockpile Ebola cholera meningococcal yellow fever vaccine two decade progress Gavi focused protecting next generation zero-dose child received even single vaccine shot Vaccine Alliance employ innovative finance latest technology – drone biometrics – save life prevent outbreak spread help country road self-sufficiency.About UNICEFUNICEF work world ’ toughest place reach world ’ disadvantaged child Across 190 country territory work every child everywhere build better world everyone information UNICEF work child visit www.unicef.org Find UNICEF ’ work COVID-19 vaccine UNICEF ’ work immunization here.About WHODedicated well-being people guided science World Health Organization lead champion global effort give everyone everywhere equal chance safe healthy life UN agency health connects nation partner people front line 150+ location – leading world ’ response health emergency preventing disease addressing root cause health issue expanding access medicine health care mission promote health keep world safe serve vulnerable www.who.int FINDFIND accelerates equitable access reliable diagnosis around world working close critical testing gap leave people risk preventable treatable illness enable effective disease surveillance build sustainable resilient health system partnership country global health agency driving progress towards global health security universal health coverage Collaborating Centre Laboratory Strengthening Diagnostic Technology Evaluation information please visit www.finddx.org